IID432
IID432 is a Trypanosoma cruzi Topoisomerase II inhibitor with an EC50 of 8 nM for Trypanosoma cruzi. IID432, a single dose of 25 mg/kg, can achieve relapse-free parasite clearance in mouse models of chronic Chagas disease. IID432 can be used for Chagas disease research[1].
Product Specifications
UNSPSC
12352005
Target
Parasite; Topoisomerase
Related Pathways
Anti-infection; Cell Cycle/DNA Damage
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
CC1=NC2=C(C=C(C=C2)N3CC[C@@H](C3)NC(CN4C=NC(C#N)=N4)=O)C=C1
Molecular Formula
C19H19N7O
Molecular Weight
361.40
References & Citations
[1]H Rachel Lagiakos, et al. Discovery of IID432: A highly efficacious and safe cyanotriazole inhibitor of Trypanosoma cruzi topoisomerase II for short-duration curative treatment of Chagas disease. ACS. 2025 Aug 20.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Topo II
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
CSB-YP742487SRE-01 10 µg
Recombinant Sudan ebolavirus Envelope glycoprotein (GP), partial
Sign In for Pricing
View Details CSB-YP742487SRE-02 50 µg
Recombinant Sudan ebolavirus Envelope glycoprotein (GP), partial
Sign In for Pricing
View Details CSB-YP742487SRE-03 200 µg
Recombinant Sudan ebolavirus Envelope glycoprotein (GP), partial
Sign In for Pricing
View Details CSB-YP742487SRE-04 500 µg
Recombinant Sudan ebolavirus Envelope glycoprotein (GP), partial
Sign In for Pricing
View Details CSB-YP742487SRE-05 100 µg
Recombinant Sudan ebolavirus Envelope glycoprotein (GP), partial
Sign In for Pricing
View Details CSB-YP742487SRE-06 1 mg
Recombinant Sudan ebolavirus Envelope glycoprotein (GP), partial
Sign In for Pricing
View Details